ArticleCancer cell international2019

Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway.

Yong-An Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.